A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model

類似資料

• Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
  著者:: Mookerjee, Ananda, 等
  出版事項: (2019)
• IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine
  著者:: Mookerjee, Ananda, 等
  出版事項: (2019)
• Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer
  著者:: Kandalaft, Lana E., 等
  出版事項: (2013)
• A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
  著者:: Kandalaft, Lana E, 等
  出版事項: (2013)
• Induced dendritic cells co-expressing GM-CSF/IFN-α/tWT1 priming T and B cells and automated manufacturing to boost GvL
  著者:: Bialek-Waldmann, Julia K., 等
  出版事項: (2021)